EMEA-001172-PIP01-11
Key facts
| Active substance |
|
| Therapeutic area |
Ophthalmology
|
| Decision number |
P/259/2011
|
| PIP number |
EMEA-001172-PIP01-11
|
| Pharmaceutical form(s) |
|
| Condition(s) / indication(s) |
Treatment of glaucoma
|
| Route(s) of administration |
Ocular use
|
| Contact for public enquiries |
Alcon Laboratories (UK) Ltd.
|
| Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|